Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  CareDx, Inc    CDNA

CAREDX, INC

(CDNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • Below the resistance at 26.17 USD, the stock shows a negative configuration when looking looking at the weekly chart.
Ratings chart
Sector Bio Diagnostics & Testing
1st jan.Capitalisation (M$)Investor Rating
CAREDX, INC1.30%937
EXACT SCIENCES CORPORATION-37.53%8 567
GUARDANT HEALTH, INC.-13.25%6 398
IOVANCE BIOTHERAPEUTICS, IN..16.19%4 068
-
ADAPTIVE BIOTECHNOLOGIES CO..-15.17%3 206
GENSCRIPT BIOTECH CORPORATI..-1.25%2 880
SEEGENE INC--.--%2 469
INVITAE CORPORATION1.30%1 394
MIRACA HOLDINGS INC.1.06%1 250
VERACYTE, INC.-17.05%1 152
THERADIAG13.60%12
More Results
Financials (USD)
Sales 2020 167 M
EBIT 2020 -21,6 M
Net income 2020 -20,1 M
Debt 2020 -
Yield 2020 -
P/E ratio 2020 -51,7x
P/E ratio 2021 937x
Capi. / Sales2020 5,60x
Capi. / Sales2021 4,32x
Capitalization 937 M
Upcoming event on CAREDX, INC
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes